Effect of Two Different Preoperative Training Densities in Patients With Non-small-cell Lung Cancer Before Lung Resection Surgery (Preo-Dens)
Pulmonary resection surgery is currently the recommended curative treatment for early stages of non-small cell lung cancer. The implementation of preoperative respiratory rehabilitation programs has shown beneficial results on pulmonary function, functional level, cardiorespiratory conditioning and the occurrence and severity of postoperative complications in this population of patients. Despite these benefits, the most recent meta-analyzes highlight the fact that training modalities (duration, frequencies, intensity) are very heterogeneous. It is then difficult to structure a program only on the basis of data from the literature.
In a cohort analysis of 50 patients trained from 2014 to 2017, our team reported a significantly greater improvement in physiological parameters in patients who performed 15 or more preoperative training sessions. This number of 15 outpatient sessions is therefore considered a minimum training goal in our current practice.
The difficulty of the oncological context is to find the compromise between the necessary diligence to initiate the cancer surgical treatment and the necessary time to obtain the benefits of the preoperative rehabilitation. Previous study reports the difficulty of setting up a four-week training program, perceived as delaying surgery. In order to prevent any risk of prolonging the surgical management time, rehabilitation teams routinely offer short programs with high training frequencies of up to five to six sessions per week. It seems important to note that preoperative rehabilitation is normally considered in patients for whom there is a risk of moderate to high postoperative complications according to the European and North American recommendations. Thus these patients generally benefit from a longer period of assessment than patients whose risk is considered low in terms of their cardio-respiratory and muscular function.
The median duration between the physiological evaluation of patients considered "at risk" before pulmonary resection surgery is 44 (Q1-Q3 29-76) days at Rouen University Hospital, with no significant differences observed between patients who have benefited or not from preoperative rehabilitation. Some teams have even pointed out that there is no difference in survival prognosis in the short or long term between patients who have had an operative delay of more or less 60 or 90 days respectively, which shows the compatibility with the set up a dedicated training course.
As mentioned earlier, the concept of delay has led to extremely dense training for a functionally and cardio-respiratory fragile target population as evidenced by pejorative VO2peak. The density of the training, failing to generate significant physiological stimulation, may increase fatigue or limit adherence to training, especially if it requires movement, and is added to a therapeutic planning including many consultations and further examinations. To date, no study has evaluated the density of preoperative supervised training on pre-surgical benefits.
The objective of this work is to compare the effectiveness of a program of 15 training sessions on VO2peak according to two different densities, namely five times a week over three weeks, or three times a week over five weeks.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Normandie
-
Bois-Guillaume, Normandie, França, 76230
- ADIR Association
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age> 18 years old;
- Beneficiary of a social security scheme;
- Non-Small Cell Lung Cancer or suspicion of bronchial neoplasia;
- Addressed to respiratory rehabilitation in a preoperative setting with a moderate to high risk estimate (VO2peak < 20 ml/kg/min);
- Intervention date not established when included in the program or ≥ 5 wk.
Exclusion Criteria:
- Patient under guardianship;
- Pregnant or lactating woman;
- Cardiological contraindication to training;
- Neoadjuvant radio-chemotherapy;
- Refusal to carry out a training program in a rehabilitation center;
- Orthopedic, neurological, vascular or neuromuscular pathology limiting training;
- Exacerbation or deterioration of the general condition requiring stopping the preoperative re-training program;
- Modification of the therapeutic project at a multidisciplinary consultation meeting requiring the cessation of rehabilitation or participation in the study.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Outro: Group 1
5 Preoperative Pulmonary Rehabilitation sessions / week during 3 weeks.
|
Each prehabilitation session will last approximately 90 minutes and will include:
|
|
Outro: Group 2
3 Preoperative Pulmonary Rehabilitation sessions / week during 5 weeks.
|
Each prehabilitation session will last approximately 90 minutes and will include:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
peak dioxyen consumption (VO2peak)
Prazo: before the preoperative training program
|
VO2peak (in ml/kg/min) measured during and incremental Cardio-Pulmonary Exercise Testing (CPET)
|
before the preoperative training program
|
|
peak dioxyen consumption (VO2peak)
Prazo: through preoperative training program completion (15 sessions)
|
VO2peak (in ml/kg/min) measured during and incremental Cardio-Pulmonary Exercise Testing (CPET)
|
through preoperative training program completion (15 sessions)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
peak work-rate (WRpeak)
Prazo: before the preoperative training program
|
maximum power reached during the Cardio-Pulmonary Exercise Testing (CPET)
|
before the preoperative training program
|
|
peak work-rate (WRpeak)
Prazo: through preoperative training program completion (15 sessions)
|
maximum power reached during the Cardio-Pulmonary Exercise Testing (CPET)
|
through preoperative training program completion (15 sessions)
|
|
oxygen consumption at ventilatory threshold (VO2vt)
Prazo: before the preoperative training program
|
oxygen consumption at ventilatory threshold recorded during the Cardio-Pulmonary Exercise Testing (CPET)
|
before the preoperative training program
|
|
oxygen consumption at ventilatory threshold (VO2vt)
Prazo: through preoperative training program completion (15 sessions)
|
oxygen consumption at ventilatory threshold recorded during the Cardio-Pulmonary Exercise Testing (CPET)
|
through preoperative training program completion (15 sessions)
|
|
work-rate at ventilatory threshold (WRvt)
Prazo: before the preoperative training program
|
work-rate at ventilatory threshold recorded during the Cardio-Pulmonary Exercise Testing (CPET)
|
before the preoperative training program
|
|
work-rate at ventilatory threshold (WRvt)
Prazo: through preoperative training program completion (15 sessions)
|
work-rate at ventilatory threshold recorded during the Cardio-Pulmonary Exercise Testing (CPET)
|
through preoperative training program completion (15 sessions)
|
|
ventilatory efficiency (VE/VCO2 slope)
Prazo: before the preoperative training program
|
linear regression of the ratio between the increase in minute ventilation and the expired carbon dioxide flow (VE/VCO2 slope)
|
before the preoperative training program
|
|
ventilatory efficiency (VE/VCO2 slope)
Prazo: through preoperative training program completion (15 sessions)
|
linear regression of the ratio between the increase in minute ventilation and the expired carbon dioxide flow (VE/VCO2 slope)
|
through preoperative training program completion (15 sessions)
|
|
body mass index (BMI)
Prazo: before the preoperative training program
|
weight in kilograms divided by the square of height in meters
|
before the preoperative training program
|
|
body mass index (BMI)
Prazo: through preoperative training program completion (15 sessions)
|
weight in kilograms divided by the square of height in meters
|
through preoperative training program completion (15 sessions)
|
|
fat-free mass
Prazo: before the preoperative training program
|
impedancemetry (Bodystat® 1500MDD, (5/50 kHz), Bodystat, Douglas, Isle of Man, UK).
|
before the preoperative training program
|
|
fat-free mass
Prazo: through preoperative training program completion (15 sessions)
|
impedancemetry (Bodystat® 1500MDD, (5/50 kHz), Bodystat, Douglas, Isle of Man, UK).
|
through preoperative training program completion (15 sessions)
|
|
quadriceps peak torque
Prazo: before the preoperative training program
|
quadriceps peak torque (in Nm) assessed by dynamometry (MicroFET2®, Hogan Health Industries, Inc., UT)
|
before the preoperative training program
|
|
quadriceps peak torque
Prazo: through preoperative training program completion (15 sessions)
|
quadriceps peak torque (in Nm) assessed by dynamometry (MicroFET2®, Hogan Health Industries, Inc., UT)
|
through preoperative training program completion (15 sessions)
|
|
maximum inspiratory pressure (MIP)
Prazo: before the preoperative training program
|
Maximum negative oral pressure generated by the patient during inspiration (in cmH2O)
|
before the preoperative training program
|
|
maximum inspiratory pressure (MIP)
Prazo: through preoperative training program completion (15 sessions)
|
Maximum negative oral pressure generated by the patient during inspiration (in cmH2O)
|
through preoperative training program completion (15 sessions)
|
|
Health related quality of life (HRQoL) questionnaire
Prazo: before the preoperative training program
|
Full name of the scale : "European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and modular supplement for Lung Cancer patients" (EORTC QLQ-C30 / LC13) The EORTC QLQ-C30, is a 30 questions questionnaire developed by the European Organization for Research and Treatment of Cancer, to assess the QoL of cancer patients. It has been translated and validated into over 100 languages and is used in more than 3,000 studies worldwide. For patients with Lung Cancer, a 13 questions modular supplement, the LC-13, is validated. The HRQoL is therefore evaluated by a set of 43 questions gathering all aspects that could be impacted. A raw score is calculated for each dimension and summary score, then standardized from 0 to 100 points. The additional module for Lung Cancer (LC-13) provides a complementary dimension with specific items related to the tumor site. (see Fayers et. al., The EORTC QLQ-C30 Scoring Manual (3rd Edition) 2001. |
before the preoperative training program
|
|
Health related quality of life (HRQoL) questionnaire
Prazo: through preoperative training program completion (15 sessions)
|
Full name of the scale : "European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and modular supplement for Lung Cancer patients" (EORTC QLQ-C30 / LC13) The EORTC QLQ-C30, is a 30 questions questionnaire developed by the European Organization for Research and Treatment of Cancer, to assess the QoL of cancer patients. It has been translated and validated into over 100 languages and is used in more than 3,000 studies worldwide. For patients with Lung Cancer, a 13 questions modular supplement, the LC-13, is validated. The HRQoL is therefore evaluated by a set of 43 questions gathering all aspects that could be impacted. A raw score is calculated for each dimension and summary score, then standardized from 0 to 100 points. The additional module for Lung Cancer (LC-13) provides a complementary dimension with specific items related to the tumor site. (see Fayers et. al., The EORTC QLQ-C30 Scoring Manual (3rd Edition) 2001. |
through preoperative training program completion (15 sessions)
|
|
Adherence to sessions
Prazo: through preoperative training program completion (15 sessions)
|
number of sessions performed on number of sessions planned
|
through preoperative training program completion (15 sessions)
|
|
Postoperative Complications
Prazo: At 30 days post-intervention
|
number and type of complication during the 30 days post lung resection.
Each complication severity is evaluated with the Clavien-Dindo scale.
|
At 30 days post-intervention
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Preo-Dens
- ID-RCB : 2018-A03301-54 (Identificador de registro: 2018-A03301-54)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Câncer de Pulmão de Células Não Pequenas
-
Taichung Veterans General HospitalConcluídoCardiotoxicidade | Carcinoma de Pulmão de Células não Pequenas (Termo MeSH: Carcinoma, Non-Small-Cell Lung) | Efeitos Secundários e Reações Adversas Relacionadas com Medicamentos (Termo MeSH) | Inibidor da Tirosina Quinase do EgfrTaiwan
-
Fondazione del Piemonte per l'OncologiaRecrutamentoCâncer de mama | Cancro do ovário | Câncer colorretal | Melanoma (câncer de pele) | Carcinoma de Pulmão de Células não Pequenas (Termo MeSH: Carcinoma, Non-Small-Cell Lung)Itália
-
Novartis PharmaceuticalsRescindidoMelanoma | Avançado EGFR mutante non Small Cell LungCancer (NSCLC) | KRAS G12-MUTANT NSCLC | Câncer de células escamosas esofágicas (SCC) | Cabeça/pescoço SCC | Tumores estromais gastrointestinais avançados (GIST) | NRAS/Braft WT avançado melanoma cutâneoEstados Unidos, Taiwan, Holanda, Canadá, Espanha, Cingapura, Itália, Japão, Coréia do Sul
Ensaios clínicos em Preoperative Pulmonary Rehabilitation
-
University Hospital, LinkoepingLinkoeping University; Ryhov County HospitalDesconhecido
-
University of KonstanzWorld BankDesconhecidoTranstorno de Estresse Pós-Traumático | Agressão ApetitivaCongo
-
Karolinska InstitutetConcluídoDerrame | Afasia | Apraxia de falaSuécia
-
Fondazione Don Carlo Gnocchi OnlusUniversità Campus Bio-Medico di Roma (UCBM); Khymeia Group S.r.l.Ainda não está recrutandoComprometimento Cognitivo Leve (MCI) | Parkinson DeseaseItália
-
Psychiatric Research Unit, Region Zealand, DenmarkRetiradoInternação Psiquiátrica
-
Federal University of BahiaConcluídoDerrame | Distúrbios CerebrovascularesBrasil
-
The University of Hong KongThe Hong Kong Jockey Club Charities Trust; Hong Kong Young Women's Christian... e outros colaboradoresRecrutamentoEstresse mentalHong Kong
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... e outros colaboradoresRecrutamentoCOVID-19 | Doença grave | Fraqueza Adquirida na UTI | Aptidão cardiorespiratória | FOTOSEstados Unidos